Trials / Recruiting
RecruitingNCT06591039
A Multicenter Prospective Observational Cohort Based on a Breast Cancer Medical Record Database in China
A Multicenter Prospective Observational Cohort Study of Breast Cancer Based on a Breast Cancer Medical Record Database in China
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 20,000 (estimated)
- Sponsor
- Fudan University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
1. To construct a prospective, multi-center breast cancer treatment cohort in China, and analyze the factors affecting breast cancer diagnosis and treatment. 2. To evaluate the diagnosis and treatment and prognosis of breast cancer among patients in different regions and hospitals.
Detailed description
This research aims to: A. Understand and analyze the current status of breast cancer diagnosis and treatment; B. Publish an annual report on diagnosis and treatment; C. Data sharing, dynamic evaluation; D. Evaluate consensus and guideline promotion and implementation effects; E. Propose and set clinical quality standards for industry associations, and propose improvement goals; F. Provide a basis for industry associations to formulate specialized training programs; G. To provide assistance in the formulation of health insurance policies; H. Provide a platform for clinical research on breast cancer; I. Provide evidence for the formulation of clinical guidelines and consensus
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | The study did not involve intervention in the patient's treatment regimen | This study is based on a prospective database platform to register the occurrence, treatment and prognosis of breast cancer in China, so there is no clear exposure factor. This study was a prospective cohort study, which did not intervene in exposure factors, but only assessed the occurrence, treatment, and prognosis of breast cancer in China. |
Timeline
- Start date
- 2022-07-01
- Primary completion
- 2025-07-01
- Completion
- 2025-12-31
- First posted
- 2024-09-19
- Last updated
- 2024-09-19
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06591039. Inclusion in this directory is not an endorsement.